LUC7L: A Potential Drug Target and Biomarker for Diseases (G55692)

Target Name: LUC7L

NCBI ID: G55692

LUC7L

LUC7L: A Potential Drug Target and Biomarker for Diseases

LUC7L (Putative RNA-binding protein Luc7-like 1) is a protein that is expressed in various tissues and cells throughout the body. It is a member of the LHC (long non-coding RNA-binding protein) family and is characterized by its ability to bind to specific RNA molecules.

Recent studies have identified LUC7L as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

One of the key reasons for the interest in LUC7L is its ability to interact with various RNA molecules, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). These molecules are often abnormally expressed in diseases and have been implicated in the development and progression of various diseases. By binding to these molecules, LUC7L can help to regulate their function and potentially disrupt their effects on the body.

In addition to its potential as a drug target, LUC7L has also been identified as a potential biomarker for various diseases. For example, some studies have suggested that LUC7L may be involved in the development and progression of cancer, particularly in the regulation of cell proliferation and apoptosis (programmed cell death).

Another potential application of LUC7L is its role in neurodegenerative diseases. LUC7L has been shown to be involved in the regulation of neurotransmitter synthesis and release in various neurons, which may be important for the function of these cells. Additionally, LUC7L has been implicated in the development and progression of neurodegenerative diseases such as Alzheimer's and Parkinson's disease.

In addition to its potential role in disease, LUC7L has also been identified as a potential drug candidate for the treatment of various psychiatric disorders. LUC7L has been shown to play a role in the regulation of mood and anxiety in animals and has been shown to be involved in the development of various psychiatric disorders.

Overall, LUC7L is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand its role in these processes and to develop effective treatments.

Protein Name: LUC7 Like

Functions: May bind to RNA via its Arg/Ser-rich domain

The "LUC7L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LUC7L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets